Table 6 Cox proportional hazards model for survival
Cox proportional hazards model for survival | HR | CI | p-value |
|---|---|---|---|
Study arm | |||
Intervention | 1 | ||
Control | 0.94 | 0.63–1.41 | 0.77 |
Gender | |||
Female | 1 | ||
Male | 0.75 | 0.48–1.17 | 0.2 |
Age (per 1 yr increase) | 0.99 | 0.97–1.02 | 0.83 |
Treatment | |||
Carboplatin/gemcitabine | 1 | ||
Cisplatin/gemcitabine | 0.75 | 0.41–1.38 | 0.36 |
Pembrolizumab | 0.75 | 0.43–1.31 | 0.31 |
Vinflunine | 0.66 | 0.09–4.95 | 0.68 |
Disease stage | |||
Locally advanced | 1 | ||
Metastatic | 4.91 | < 0.0001 |